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Sunday, March 1, 2009 129aon actin dynamics affect elastic properties of actin-mediated linkages with the
sarcolemma. Future experiments using expressed fragments of dystrophin and
utrophin and their functionally relevant mutants will determine which structural
elements of these proteins are critical in determination of the flexibility of actin
filaments and what level of actin flexibility is physiologically optimal.
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Tropomyosins (TMs) are a family of proteins which regulate actin interactions
with myosins and other actin-binding proteins. TMs flexibility is thought to un-
derlie the mechanism of TM-dependent regulation. In this work involvement of
C-terminal sequence of TM in myosin-induced shift of TM during filament ac-
tivation was analyzed. Recombinant aTM variants with C-terminus encoded by
exon 9a (TM1b9a) or 9d (TM5a) were used. Both isoforms belong to short class
of TMs with N-terminus encoded by exon 1b. To assess the degree of TM flex-
ibility we measured FRET between AEDANS, which was attached to each TM
isoform either in Cys153 or in Cys28, and DABMI bound to actin in Cys374.
TM’s Cys153 is a native residue located in central region of TM, Cys28 was in-
troduced in N-terminal region using recombinant DNA methods. When bound
to actin alone both TM isoforms show moderate flexibility with TM-actin dis-
tances ranging between 38.5 and 44.3 A˚. Myosin S1 induced>10 A˚ movement
of N-terminal region of TM5a, whereas it’s central region was moved by about
4 A˚. More uniform movement of the central and N-terminal regions was ob-
served for TM1b9a. We conclude that TM’s C-terminal sequence determines
flexibility of the molecule. Supported by The Wellcome Trust.
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M-RIP has been shown to interact with actin, myosin, RhoA and the targeting
subunit ofmyosin phosphatase, and has been proposed to be a scaffolding protein
that anchors RhoA andRho kinase ontomyosin phosphatase and the actomyosin
cytoskeleton. The N-terminal portion of M-RIP has 2 pleckstrin homology do-
mains at residues 44–152 and 387–484 (PH1 and PH2, respectively). Mulder
et al. (J. Biol. Chem. 278, 27216–23, 2003) showed that the actin-binding activ-
ity of M-RIP resides in its N-terminal portion, and characterized the interaction
betweenPH1andF-actin, but did not investigate the role of PH2 inM-RIP’s actin
binding activity. In this work we examined the contributions of PH1 and PH2 to
the M-RIP-F-actin interaction by, first, constructing 3 deletion mutants of M-
RIP: M-RIP(1-386) (PH1), M-RIP(146-492) (PH2) and M-RIP(1-492) (PH1
and PH2). Co-sedimentation experiments with F-actin were then carried out at
low or high speeds to sedimentM-RIP-bound to F-actin bundles or filaments, re-
spectively. The following results were obtained: 1) The extent of bundle forma-
tion increases in the order M-RIP(1-386) <M-RIP(146-492)<M-RIP(1-492).
2) The extent of total actin binding increases in the order M-RIP(1-386) < M-
RIP(146-492)<M-RIP(1-492). Sequence homology analysis revealed that cer-
tain basic residues known to be important for actin binding in other PH domain-
containing proteins (Yao et al. J. Biol. Chem. 274, 19752–61, 1999) are present
in PH2.Mutagenesis of three such residues, Lys404, 405 and 396, into Ala elim-
inated the binding between M-RIP(1-492) and F-actin. Taken together our re-
sults show that the binding of M-RIP to F-actin is mediated primarily via its
PH2 domain, in particular via ionic interactions between certain basic residues
in PH2 and acidic residues in actin. (Supported byNIHAR41637 andAR49066).
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Recently Ca2þ-Calmodulin-dependent protein kinase II (CaMKII), an abundant
synaptic protein,was shown to be important in the organization of actin filaments
at synapses. We report the binding properties and mechanistic role of bCaMKII
as an actin binding protein in vitro. A particular case is the ability of bCaMKII to
bundle actin filaments, which we corroborated by cryo-electron tomography. In
addition, a pyrene-actin fluorescent polymerization assay was used to determine
that the enzyme reduced the rate of polymerization by ~ 80%, suggesting that
bCaMKII either serves as a capping protein or binds monomeric actin reducing
the amount of freely availablemonomers to nucleate polymer assembly. Finally,
by means of fluorescent cross correlation spectroscopy we determined that the
b isoformofCaMKII does bind tomonomeric actin, reaching saturation at a stoi-
chiometry of 6:1 actin mononmers per bCaMKII holoenzyme with a binding af-finity of ~2mM. In conclusion,bCaMKII has a dual functional role; it can seques-
ter monomeric actin to reduce actin polymerization and can also bundle actin
filaments. Together, these effects would impact both the dynamics of assembly
of actin filaments and enhance the structural rigidity of the filaments once
formed, significantly impacting the structure of synapses.
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Actin cytoskeletal rearrangements are orchestrated by a vast number of actin
binding proteins. Coactosin is a 17kDa actin binding protein originally discov-
ered in Dictyostelium discoideum. The protein has an ADF-homology domain
(ADF-H-domain) also found in cofilin, twinfilin, and drebrin. It was shown that
coactosin interferes with capping proteins, but in the absence of capping pro-
teins it does not influence on actin polymerization. We used electron micros-
copy and the IHRSR method to reconstruct actin filaments stoichiometrically
decorated with coactosin. In contrast toADF/cofilin, coactosin does not change
the twist of F-actin. Nevertheless, coactosin utilizes a similar interface on F-ac-
tin to that used by ADF/cofilin. Our data are consistent with the solution struc-
tural studies on coactosin showing that the regions of ADF/cofilin involved in
the interaction with F-actin are structurally conserved in coactosin.
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Kinetic and structural studies ofActin-related protein (Arp) 2/3 complex point to
a transition from inactive to active conformations at an actin branch point. The
inactive conformation is greatly favored for purified Arp2/3 complex. Crystal
structures of inactive Arp2/3 complex show that Arp2 and Arp3 are separated
by about 3 nmcompared to their positions as the first two subunits of the daughter
filament in low resolution models based in reconstructions from electron tomo-
grams of actin filament branch junctions.Here, we use atomistic-scalemolecular
dynamics simulations to study activation of Arp2/3 complex. Starting in the
ATP-bound inactive crystal structure, we apply forces to Arp2 and Arp3 so
that the energy of the system is at aminimumwhenArp2 andArp3 are positioned
like the first and second subunits of the daughter filament. Arp2 does not detach
from the other subunits during activation as proposed from biochemical exper-
iments. The long C-terminal a-helix of p34 rotates along with Arp2 and p40
through interactions with p20. Residues His30-Leu35 of p20 stay in contact
with the residues of theaGhelix ofArp2 throughout the course of the simulation.
Also, residuesArg106-Lys107 of p20 interact with the region of Arp2 surrounding
Leu235 between the aF and aG loops. The main impediment to a smooth transi-
tion is theaKhelix of subdomain 3 ofArp3, which collideswith theDNase bind-
ing loop of Arp2. This study provides the first insights into the conformational
changes of Arp2/3 complex forms an actin filament branch.
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Calponin is an actin binding, troponin-like molecule, first isolated from chicken
gizzard smooth muscle cells where it is involved in regulation of contractility.
So far there are three known isoforms, basic, acidic and neutral Calponin, each
encoded by a separate gene. Expression of the acidic Calponin isoform is, un-
like basic Calponin, not restricted to smooth muscle cells but is expressed in
a variety of tissues and cell types, especially in the brain. For basic Calponin
it is known that the molecule affects smooth muscle cell contractility by regu-
lation of the PKC/ERK signaling pathway. Here we could show that acidic Cal-
ponin co-precipitates together with ERK1/2 and PKCalpha in the cultured rat
fibroblast cell line REF52.2. Moreover it colocalises with ERK1/2 and PKCal-
pha in podosome-like structures and at the cell cortex after Phorbol-12,13-Di-
butyrate (PDBu) treatment. Knockdown of acidic Calponin expression in these
cells results in inhibition of PDBu-mediated ERK1/2 translocation to these
structures, whereas PKCalpha targeting is not affected. Both endogenous
ERK1/2 activity and phosphorylation of the ERK1/2 substrate l-Caldesmon
are blocked by acidic Calponin knockdown, indicating an important role for
the acidic Calponin isoform in regulation of ERK1/2 function in REF52.2 cells.
Abstract sponsored by John Gergely, Boston Biomedical Research Institute,
Watertown 02472, MA, USA
Support: NIH grants HL80003, HL86655
